Polymyxin B and Trimethoprim Ophthalmic Solution Recalled Due to Temperature Abuse
McKesson Medical-Surgical is recalling Polymyxin B and Trimethoprim Ophthalmic Solution nationwide due to temperature deviations during manufacturing. The medication may not work as intended.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for manufacturing quality deviations with no reported illnesses or injuries. This is a precautionary recall where the hazard—potential loss of medication efficacy—is theoretical and does not involve documented harm.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP, sterile 0.1%, 10 mL bottles, Rx only, due to cGMP (current Good Manufacturing Practice) deviations involving temperature abuse. The product was manufactured by Sandoz Pharma.
Temperature deviations during manufacturing may affect the stability and effectiveness of these antibiotic eye drops. Polymyxin B and Trimethoprim are used to treat bacterial eye infections.
The recalled product was distributed nationwide in the USA, affecting approximately 44 bottles. McKesson Medical-Surgical is unable to determine specific lot numbers or which customers received affected product. Each customer notification included the distribution date and shipment dates of potentially affected product.
Patients and healthcare providers should discontinue use of the recalled medication and contact a healthcare provider or pharmacist for a replacement. The recalled product can be identified by NDC code 6131462810.
The recalled product
- Product
- Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP, sterile, 0.1%, 10 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131462810
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug
- Hazard
- temperature-abuse
- efficacy-loss
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27